Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Budesonide/Formoterol vs Symbicort in Asthma
NCT02495168Phase 3Completed
- Sponsor
- Allergan
- Start
- Jan 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE, formoterol in asthma, sponsored by Allergan. Started Jan 2017; status: completed.
02
Drugs
EPI-EEformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02495168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495168.